[Drug release in vitro from digoxin formulations with high bioavailability (author's transl)].
The drug release of four brands of digoxin tablets (A, B, C, D) with known bioavailability was examined using three liberation systems. The paddle method (1) could only ascertain a uniformly good release of all brands. A flow-cell (II) and a special method testing the supersaturation (III) indicated significant differences in drug release. Both II and III pointed to the brand having the best bioavailability. Beyond it no satisfactory correlation was found between the values of bioavailability and drug release.
D001682:Biological Availability; D002626:Chemistry, Pharmaceutical; D004077:Digoxin / Q000378:metabolism*
D004077:Digoxin
Wirkstoffliberation in vitro bei Digoxin-Präparaten mit hoher Bioverfügbarkeit.